24501686
2013 Dec 1
Natural killer (NK) cells play a major role in antitumor immune responses. Recent results from our laboratory demonstrate the impact of the immunogenetic background on the activity of NK cells and hence on the outcome of hepatocellular carcinoma, disclosing perspectives for the development of NK-cell based therapies.
CD56; HCC; HLA; immunotherapy; killer cell Ig-like receptor; natural killer cell.
